for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Eurofins Scientific SE

EUFI.PA

Latest Trade

67.19EUR

Change

-0.36(-0.53%)

Volume

392,381

Today's Range

66.94

 - 

67.92

52 Week Range

39.30

 - 

75.40

As of on the Euronext Paris ∙ Minimum 15 minute delay

Pricing

Previous Close
67.55
Open
67.45
Volume
392,381
3M AVG Volume
6.88
Today's High
67.92
Today's Low
66.94
52 Week High
75.40
52 Week Low
39.30
Shares Out (MIL)
18.98
Market Cap (MIL)
13,121.19
Forward P/E
30.98
Dividend (Yield %)
--

Next Event

Eurofins Scientific SE Split For ERRFY.PK - Ratio 5-2

Latest Developments

More

Eurofins Viracor Launches Combined Covid-19, Influenza, RSV Test

Eurofins CDMO Announces Expansion Of Drug Product Capabilities In Canada

Eurofins Launches Sars-Cov-2 Test Kits For Sanger Sequencing Equipment

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Eurofins Scientific SE

Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain. It is active through Ahma Group, Villapharma, Exova's environment testing laboratories in Eastern Canada, ASL analises ambientais in Brazil, MVZ fur Laboratoriumsmedizin am Hygiene-Institut Gmbh, Alphora Research, Genoma Laboratory Group, Ana Laboratories Inc, Lifecodexx AG, Gatc Biotech AG, Japan Analytical Chemistry Consultants Co. Ltd. (''Jacc''), Tsing Hua and Ecopro Research K.K. (''Ecopro'') and Craft Technologies.

Industry

Biotechnology & Drugs

Contact Info

23 val Fleuri

1526

Luxembourg

https://www.eurofins.com/

Executive Leadership

Gilles G. Martin

Chairman of the Board, Chief Executive Officer

Valerie Hanote

Executive Director

Yves-Loic Martin

Executive Director

Stuart Anthony K. Anderson

Non-Executive Independent Director

Patrizia Luchetta

Non-Executive Independent Director

Key Stats

2.38 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2017

3.0K

2018

3.8K

2019

4.6K

2020(E)

5.2K
EPS (EUR)

2017

1.662

2018

1.707

2019

1.669

2020(E)

2.196
Price To Earnings (TTM)
37.41
Price To Sales (TTM)
2.78
Price To Book (MRQ)
3.81
Price To Cash Flow (TTM)
14.51
Total Debt To Equity (MRQ)
93.32
LT Debt To Equity (MRQ)
85.52
Return on Investment (TTM)
6.38
Return on Equity (TTM)
4.95

Latest News

Latest News

BRIEF-Eurofins Scientific: COVID-19 Sentinel RT-PCR Eurofins Tests Can Contribute To Detection Of Asymptomatic Virus

* PUBLISHES A METHOD FOR EARLY DETECTION OF ASYMPTOMATIC SPREADERS OF THE SARS-COV-2 VIRUS, WHICH DOES NOT REQUIRE CLINICAL PCR TESTING IN HUMANS

BRIEF-Eurofins Publishes Method For Early Detection Of Asymptomatic SARS-COV-2 Virus Spreaders

* EUROFINS PUBLISHES METHOD FOR EARLY DETECTION OF ASYMPTOMATIC SARS-COV-2 VIRUS SPREADERS, THAT DOES NOT REQUIRE HUMAN PCR CLINICAL TESTING

BRIEF-Euronext announces quarterly revision of French indices

Euronext NV announced on Thursday quarterly review of the CAC family indices: CAC 40 Index Inclusion of: Exclusion of: TELEPERFORMANCE SODEXO SBF 120 Index Inclusion of: Exclusion of: ALBIOMA EUROPCAR MOBILITY NEOEN QUADIENT ROBERTET VERALLIA CAC Next 20 Index Inclusion...

BRIEF-Eurofins To Issue 900,000 New Shares Via Accelerated Book Building Offering

* EUROFINS ANNOUNCES THE ISSUANCE OF C. 900,000 NEW SHARES VIA AN ACCELERATED BOOK BUILDING OFFERING TO INSTITUTIONAL INVESTORS IN ORDER TO SUPPORT ITS RAPID BUILD-UP OF COVID-19 TESTING CAPACITIES

BRIEF-Eurofins: launches serologic products for testing kits to deal with COVID-19

* EUROFINS TECHNOLOGIES LAUNCHES MULTIPLE CE-IVD MARKED SEROLOGIC PRODUCTS FOR THE DETECTION OF ANTIBODIES IN PATIENTS WHO HAVE BEEN EXPOSED TO SARS-COV-2 (COVID-19)

BRIEF-Eurofins Scientific: Transplant Genomics Announces Patient Enrollment In TRULO Registry Study

* TRANSPLANT GENOMICS TODAY ANNOUNCED PATIENT ENROLLMENT WILL BEGIN IN THEIR TRULO ("TRUGRAF LONG-TERM CLINICAL OUTCOMES") REGISTRY STUDY Source text for Eikon: Further company coverage: (Gdansk Newsroom)

BRIEF-Eurofins Scientific Launches Products For Patients Exposed To COVID-19

* EUROFINS TECHNOLOGIES LAUNCHES MULTIPLE NEW PRODUCTS FOR SEROLOGIC DETECTION OF ANTIBODIES IN PATIENTS WHO HAVE BEEN EXPOSED TO COVID-19

BRIEF-Eurofins Scientific: offering full range of tests to treat COVID pandemic

* Its laboratories across the U.S.A., Europe and Asia are now providing a global service offer for testing, inspection and regulatory services focused on medical face masks, gloves and gowns, respiratory protective devices and equipment, its materials and components, as...

BRIEF-Eurofins Scientific: Eurofins Technologies Launches Testing Solutions For Detection Of Sars-Cov-2

* EUROFINS TECHNOLOGIES LAUNCHES TESTING SOLUTIONS FOR DETECTION OF SARS-COV-2 ON ENVIRONMENTAL SURFACES

BRIEF-Eurofins Scientific Offers Additional Testing Options for Detection Of COVID-19

* EUROFINS SCIENTIFIC SUPPORTS HEALTHCARE AUTHORITIES IN EUROPE, THE U.S.A. AND BRAZIL IN THEIR FIGHT AGAINST THE COVID-19 PANDEMIC WITH ADDITIONAL TESTING OPTIONS AND FAST GROWING CAPACITY

BRIEF-Eurofins Scientific Supports SARS-CoV-2 Analyses Needs With Testing Options

* EUROFINS SCIENTIFIC SUPPORTS SARS-COV-2 ANALYSES NEEDS IN THE U.S.A. AND IN EUROPE WITH MULTIPLE TESTING OPTIONS

Eurofins to slow pace of M&A, expand in emerging markets

Laboratory-testing company Eurofins Scientific <EUFI.PA> plans to slow its frantic dealmaking pace in the next two years while also expanding in emerging markets to maintain double-digit sales growth over the next decade, its finance director said.

Eurofins Scientific detects ransomware in some of its IT systems

Food and biopharma product testing company Eurofins Scientific said on Monday that some of its IT systems were affected by a form of ransomware during the weekend.

Eurofins Scientific raises outlook after acquisitions, third-quarter growth

Luxembourg-based food and biopharma product testing firm Eurofins Scientific <EUFI.PA> raised its earnings expectations for 2019 and 2020 for the second time this year on Tuesday following acquisitions and a strong third quarter.

Eurofins ups revenue target after US clears Covance acquisition

Eurofins said on Wednesday it was raising its revenue target after receiving antitrust clearance for its acquisition of U.S. food company Covance.

BRIEF-Eurofins Scientific Acquires LabCorp's Food Testing And Consulting Business

* ACQUISITION OF LABCORP’S FOOD TESTING AND CONSULTING BUSINESS

BRIEF-Eurofins Acquires Food Analytica Group in Hungary

* EUROFINS ENTERS THE HUNGARIAN MARKET FOR FOOD AND FEED TESTING WITH THE ACQUISITION OF FOOD ANALYTICA GROUP Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up